New, Molecular Cervical Cancer Screening Technologies: Results From PATH's START-UP Project

This brief describes two human papillomavirus (HPV) screening methods developed and tested by PATH for low-resource settings: the careHPV™ DNA test and the OncoE6™ cervical test.

Publication date: April 2013

New, Molecular Cervical Cancer Screening Technologies

566.3 KB PDF

Hard copies are not available.

View Resource